QHSLab, Inc. (USAQ)
- Previous Close
0.1300 - Open
0.1010 - Bid 0.0875 x --
- Ask 0.1200 x --
- Day's Range
0.1010 - 0.1040 - 52 Week Range
0.0160 - 0.3500 - Volume
12,264 - Avg. Volume
7,850 - Market Cap (intraday)
1.091M - Beta (5Y Monthly) -0.62
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.
www.usaqcorp.comRecent News: USAQ
View MorePerformance Overview: USAQ
Trailing total returns as of 9/25/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: USAQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: USAQ
View MoreValuation Measures
Market Cap
1.09M
Enterprise Value
2.66M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.63
Price/Book (mrq)
--
Enterprise Value/Revenue
1.65
Enterprise Value/EBITDA
24.62
Financial Highlights
Profitability and Income Statement
Profit Margin
-11.81%
Return on Assets (ttm)
-1.41%
Return on Equity (ttm)
--
Revenue (ttm)
1.61M
Net Income Avi to Common (ttm)
-190.5k
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
104.2k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
92.44k
Research Analysis: USAQ
View MoreCompany Insights: USAQ
USAQ does not have Company Insights